PFIZER Financial Statement Analysis
|
||
|
The Revenues of PFIZER have increased by 4.02% YoY .
The Earnings Per Share (EPS) of PFIZER has increased by 39.22 % YoY. |
||
PFIZER Last 5 Annual Financial Results
[BOM: 500680|NSE : PFIZER]
| Standalone | Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|---|
| Revenues | ₹2,281 Cr | ₹2,193 Cr | ₹2,425 Cr | ₹2,611 Cr | ₹2,239 Cr |
| Expenses | ₹1,541 Cr | ₹1,558 Cr | ₹1,616 Cr | ₹1,775 Cr | ₹1,526 Cr |
| Operating Profit (Excl OI) | ₹740 Cr | ₹635 Cr | ₹809 Cr | ₹836 Cr | ₹712 Cr |
| Other Income | ₹172 Cr | ₹181 Cr | ₹101 Cr | ₹63 Cr | ₹81 Cr |
| Interest | ₹8.50 Cr | ₹15 Cr | ₹13 Cr | ₹11 Cr | ₹15 Cr |
| Depreciation | ₹61 Cr | ₹62 Cr | ₹106 Cr | ₹115 Cr | ₹109 Cr |
| Profit Before Tax | ₹1,016 Cr | ₹746 Cr | ₹824 Cr | ₹773 Cr | ₹669 Cr |
| Profit After Tax | ₹768 Cr | ₹551 Cr | ₹624 Cr | ₹613 Cr | ₹498 Cr |
| Earnings Per Share (Rs) | ₹167.78 | ₹120.51 | ₹136.38 | ₹133.89 | ₹108.77 |
| PAT Margin (%) | 32.15 | 23.81 | 24.37 | 22.56 | 22.23 |
| ROE(%) | 19.65 | 16.21 | 20.55 | 23.30 | 17.19 |
| ROCE(%) | 26.21 | 22.37 | 27.56 | 29.78 | 23.62 |
| Total Debt/Equity(x) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Key Financials |
||
| Market Cap | : | ₹ 20,896.6 Cr |
| Revenue (TTM) | : | ₹ 2,519.7 Cr |
| Net Profit(TTM) | : | ₹ 722.4 Cr |
| EPS (TTM) | : | ₹ 158.1 |
| P/E (TTM) | : | 28.9 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| PFIZER | 2.6% | -3.3% | -21.7% |
| SUN PHARMACEUTICAL INDUSTRIES | 0.6% | -2.8% | 6.2% |
| DIVIS LABORATORIES | 0.4% | 0.1% | 0.1% |
| TORRENT PHARMACEUTICALS | 3.4% | 4.3% | 42% |
| CIPLA | -1.3% | 7% | -7.6% |
| DR REDDYS LABORATORIES | -0.2% | 0.4% | -1.4% |
| MANKIND PHARMA | 1.5% | -0.2% | 0.4% |
| LUPIN | 0.3% | 1.3% | 12.7% |
| ZYDUS LIFESCIENCES | 1.5% | 18.8% | 14.9% |
PFIZER Revenues
[BOM: 500680|NSE : PFIZER]
| Y-o-Y | 4.02 % |
| 5 Yr CAGR | 0.47 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,281 Cr | 4.02 | |
| Mar2024 | ₹2,193 Cr | -9.55 | |
| Mar2023 | ₹2,425 Cr | -7.13 | |
| Mar2022 | ₹2,611 Cr | 16.64 | |
| Mar2021 | ₹2,239 Cr | - | |
PFIZER Operating Profit
[BOM: 500680|NSE : PFIZER]
| Y-o-Y | 16.53 % |
| 5 Yr CAGR | 0.97 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹740 Cr | 16.53 | |
| Mar2024 | ₹635 Cr | -21.46 | |
| Mar2023 | ₹809 Cr | -3.23 | |
| Mar2022 | ₹836 Cr | 17.34 | |
| Mar2021 | ₹712 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 12.01 % |
| 5 Yr CAGR | 0.49 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2025 | 32.45% | 12.01 | |
| Mar2024 | 28.97% | -13.16 | |
| Mar2023 | 33.36% | 4.18 | |
| Mar2022 | 32.02% | 0.63 | |
| Mar2021 | 31.82% | - | |
PFIZER Profit After Tax
[BOM: 500680|NSE : PFIZER]
| Y-o-Y | 39.23 % |
| 5 Yr CAGR | 11.45 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹768 Cr | 39.23 | |
| Mar2024 | ₹551 Cr | -11.64 | |
| Mar2023 | ₹624 Cr | 1.86 | |
| Mar2022 | ₹613 Cr | 23.10 | |
| Mar2021 | ₹498 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 35.03 % |
| 5 Yr CAGR | 9.66 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2025 | 32.15 % | 35.03 | |
| Mar2024 | 23.81 % | -2.30 | |
| Mar2023 | 24.37 % | 8.02 | |
| Mar2022 | 22.56 % | 1.48 | |
| Mar2021 | 22.23 % | - | |
PFIZER Earnings Per Share (EPS)
[BOM: 500680|NSE : PFIZER]
| Y-o-Y | 39.22 % |
| 5 Yr CAGR | 11.44 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2025 | ₹168 | 39.22 | |
| Mar2024 | ₹121 | -11.64 | |
| Mar2023 | ₹136 | 1.86 | |
| Mar2022 | ₹134 | 23.09 | |
| Mar2021 | ₹109 | - | |
PFIZER Return on Capital Employed (ROCE)
[BOM: 500680|NSE : PFIZER]
| Y-o-Y | 17.17 % |
| 5 Yr CAGR | 2.64 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2025 | 26.21% | 17.17 | |
| Mar2024 | 22.37% | -18.83 | |
| Mar2023 | 27.56% | -7.45 | |
| Mar2022 | 29.78% | 26.08 | |
| Mar2021 | 23.62% | - | |
PFIZER Share Price vs Sensex
| Current Share Price | : | ₹4,572.6 |
| Current MarketCap | : | ₹ 20,896.6 Cr |
| Updated EOD on | : | Jun 11,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PFIZER | 2.6% |
-3.3% |
-21.7% |
| SENSEX | -0.7% |
-2.9% |
-8.9% |
PFIZER related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE HEALTHCARE | 0.9% | 0.6% | 10.4% |
| BSE 500 | -1.7% | -3.1% | -3.4% |
| BSE 1000 | -1.7% | -3% | -3.2% |
| BSE 250 SMALLCAP INDEX | -2.4% | -3.7% | -2.5% |
| BSE 400 MIDSMALLCAP INDEX | -2.6% | -3.6% | -0.9% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY500 HEALTHCARE INDEX | 1% | 0.5% | NA |
| NIFTY MIDSMALL HEALTHCARE | 0.4% | -0.1% | 15.8% |
| NIFTY 500 | -1.7% | -3% | -3% |
| NIFTY TOTAL MARKET | -1.7% | -2.9% | -3% |
| NIFTY MIDSMALL INDIA CONSUMPTION | -1.8% | -4.3% | -10.1% |
You may also like the below Video Courses
FAQ about PFIZER Financials
How the annual revenues of PFIZER have changed ?
The Revenues of PFIZER have increased by 4.02% YoY .
How the Earnings per Share (EPS) of PFIZER have changed?
The Earnings Per Share (EPS) of PFIZER has increased by 39.22 % YoY .
Check out Intrinsic Value of Peers of PFIZER
Compare Stock Analytics of Peers of PFIZER
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
